Iridex (IRIX) Operating Margin Growth (3y) (2013 - 2026)

Iridex (IRIX) Operating Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -343.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 17.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 78.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -283.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1,505.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 2,016.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -184.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Iridex 15.93 Mn 11.33 Mn 4.74 Mn 1,436.00

Historic Data

Download Data
DateValue
Apr 4, 2026 1,436.00
Jan 3, 2026 918.00
Sep 27, 2025 28.00
Jun 28, 2025 878.00
Mar 29, 2025 1,529.00
Dec 28, 2024 23.00
Sep 28, 2024 11.00
Jun 29, 2024 -1,241.00
Mar 30, 2024 -1,261.00
Sep 30, 2023 783.00
Jul 1, 2023 2,225.00
Apr 1, 2023 122.00
Dec 31, 2022 447.00
Oct 1, 2022 579.00
Jul 2, 2022 797.00
Apr 2, 2022 1,165.00
Jan 1, 2022 2,118.00
Oct 2, 2021 1,077.00
Jul 3, 2021 2,338.00
Apr 3, 2021 2,264.00